Evidence map›Paper›PMID 22751136›Full record

ArticleCancer research2012

Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer.

Daniel Kreisel, Andrew E Gelman, Ryuji Higashikubo, Xue Lin, Haris G Vikis, J Michael White, Kelsey A Toth, Charuhas Deshpande, Beatriz M Carreno, Ming You and 5 more

Abstract read
In one paragraph

Article in Cancer research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Genetic diversity and tumor immunesurveillance.Journal of thoracic disease · 2013
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Daniel KreiselDepartments of Surgery, Pathology and Immunology, and Internal Medicine,The Alvin Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA.
Andrew E Gelman
Ryuji Higashikubo
Xue Lin
Haris G Vikis
J Michael White
Kelsey A Toth
Charuhas Deshpande
Beatriz M Carreno
Ming You
Samantha M Taffner
Wayne M Yokoyama
Jack D Bui
Robert D Schreiber
Alexander S Krupnick
University of California, San Diego · USMedical College of Wisconsin · USHoward Hughes Medical Institute · USUniversity of Pennsylvania · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Viral Discovery in Rheumatoid ArthritisP30AR048335 · NIAMS · WASHINGTON UNIVERSITY · PI BYUN, MINJI · 2001 to 2015
$8.9M
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTIONR01HL094601 · NHLBI · WASHINGTON UNIVERSITY · PI Andrew Eric Gelman, Daniel Kreisel · 2009 to 2026
$6.9M
Translational Insights into Estrogen Receptor alpha-Positive Luminal Breast CanceU01CA141541 · NCI · WASHINGTON UNIVERSITY · PI CARDIFF, ROBERT D, SCHREIBER, ROBERT DAVID · 2009 to 2013
$3.8M
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITINGR01CA043059 · NCI · WASHINGTON UNIVERSITY · PI SCHREIBER, ROBERT DAVID · 1986 to 2014
$3.8M
MECHANISMS OF LUNG ALLOGRAFT ACCEPTANCER01HL113931 · NHLBI · WASHINGTON UNIVERSITY · PI KREISEL, DANIEL, KRUPNICK, ALEXANDER S. · 2012 to 2015
$1.5M
MOLECULAR REGULATION OF MACROPHAGE CYTOCIDAL ACTIVITYR37CA043059 · NCI · WASHINGTON UNIVERSITY · PI SCHREIBER, ROBERT DAVID · 1995 to 2002
$1.2M
The Role of Non-Hematopoietic Cells in Tumor Tolerance InductionK08CA131097 · NCI · WASHINGTON UNIVERSITY · PI KRUPNICK, ALEXANDER S. · 2008 to 2012
$710k
Howard Hughes Medical InstituteNCI NIH HHS CA141541NCI NIH HHS CA43059NCI NIH HHS K08 CA131097NCI NIH HHS KO8CA131097NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA043059NCI NIH HHS R37 CA043059NCI NIH HHS U01 CA141541NHLBI NIH HHS 1R01HL094601NHLBI NIH HHS R01 HL094601NHLBI NIH HHS R01 HL113931NIAMS NIH HHS P30 AR048335NIAMS NIH HHS P30 AR48335
6 · The paper itself

Abstract

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide and results from a complex interaction between carcinogen exposure and inherent susceptibility. Despite its prevalence, genetic factors that predispose to the development of lung cancer remain elusive. Inbred mouse models offer a unique and clinically relevant tool to study genetic factors that contribute to lung carcinogenesis due to the development of tumors that resemble human adenocarcinoma and broad strain-specific variation in cancer incidence after carcinogen administration. Here, we set out to investigate whether strain-specific variability in tumor immunosurveillance contributes to differences in lung cancer. Using bone marrow transplantation, we determined that hematopoietic cells from lung cancer-resistant mice could significantly impede the development of cancer in a susceptible strain. Furthermore, we show that this is not due to differences in tumor-promoting inflammatory changes or variability in immunosurveillance by the adaptive immune system but results from strain-specific differences in natural killer (NK) cell cytotoxicity. Using a newly discovered congenic strain of mice, we show a previously unrecognized role for strain-specific polymorphisms in the natural killer gene complex (NKC) in immunosurveillance for carcinogen-induced lung cancer. Because polymorphisms in the NKC are highly prevalent in man, our data may explain why certain individuals without obvious risk factors develop lung cancer whereas others remain resistant to the disease despite heavy environmental carcinogen exposure.

Indexed as

Immunologic SurveillanceAdaptive ImmunityAnimalsBone Marrow CellsCarcinogensCarcinoma, Non-Small-Cell LungCell Line, TumorChromosomesHumansImmunity, InnateInflammationKiller Cells, NaturalLung NeoplasmsMaleMiceMice, 129 StrainCarcinogensUrethane

Identifiers

PMID22751136
PMCPMC3432713
OpenAlexW2011680186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.